NSRX Nasus Pharma Ltd.
Company Analysis
Latest News
🔴 Nasus Pharma is trading 8.6% down today after CFO Eyal Rubin announces departure
Nasus Pharma is trading 8.59% down now at $3.51 after announcing on August 19, 2026, that CFO Eyal Rubin will leave for an opportunity outside the life-science...
🔴 Nasus Pharma is trading 6.66% down in pre-market after CFO Eyal Rubin's departure announcement
Nasus Pharma is trading 6.66% down in pre-market at $3.58 after announcing that CFO Eyal Rubin will leave for a new opportunity outside the life-science...
🟢 Nasus Pharma is trading 10.66% up today in after-hours trading after strong first-half 2026 financial results
Nasus Pharma is trading 10.66% up at $3.84 in after-hours trading, likely driven by the positive first-half 2026 financial results released on August 17,...
🟢 Nasus Pharma rises 5.2% — Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation
With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...
🔴 Nasus Pharma is trading 5% down today after first-half net loss widened to $5.9 million
Nasus Pharma is trading at $3.46, down 5.08%, after investors reacted to its August 17, 2026 first-half results and business update, which showed net loss...
🔴 Nasus Pharma is trading 5% down in pre-market after first-half loss widened
Nasus Pharma is trading 5.21% down now at $3.46 after investors reacted to its August 17 first-half results and business update. - Reported a $5.94 million...
Nasus Pharma's Loss Balloons as Cash Clock Ticks — Can a Nasal Spray Bet Justify the Burn?
Shares of Nasus Pharma (NSRX) slid 9% to $3.37 after the Tel Aviv-based clinical-stage biotech reported first-half results that spooked investors with a...
🔴 Nasus Pharma is trading 9% down today after wider first-half losses
Nasus Pharma is trading 8.97% down now at $3.37 after its August 17, 2026, first-half results showed a net loss widening to $5.9 million from $1.3 million year...
🔴 Nasus Pharma is trading 5.65% down today after first-half results showed wider net loss and going-concern risk
Nasus Pharma is trading at $3.42, down 5.65%, after releasing first-half 2026 financial results on August 17, 2026: - Net loss widened to $5.9 million from...
🟢 Nasus Pharma is trading 11.25% up today — reason unconfirmed
Nasus Pharma is trading at $3.56 (+11.25%), with the reason unconfirmed. - No company-specific announcement, filing, earnings release, or analyst action was...
🟢 Nasus Pharma is trading 7.5% up today with no clear catalyst identified
Nasus Pharma is trading 7.5% up at $3.44, with no clear catalyst identified. - The stock closed at $3.20 on August 13, 2026. - No company-specific...
🔴 Nasus Pharma is trading 5.04% down in after-hours trading on August 13, 2026
Nasus Pharma is trading 5.04% down at $3.20 after closing the regular session at $3.37, with no company-specific catalyst identified. - Searches found no...
🟢 Nasus Pharma is trading 7.15% up today amid broader risk-on market sentiment
Nasus Pharma is trading 7.15% higher at $3.47, amid a broader risk-on session. - The S&P 500 and Nasdaq Composite are both rising more than 0.5%. - No clear...
🔴 Nasus Pharma is trading 5.82% down today; no clear catalyst identified
Nasus Pharma is trading 5.82% down at $3.05, with the immediate reason unclear. - No new August 13, 2026 company announcement, filing, analyst action, or...
🔴 Nasus Pharma is trading 5% down today with no clear company-specific catalyst identified
Nasus Pharma is trading at $3.28, down 5.07%, with no clear company-specific announcement identified for August 10, 2026. • The June 9 NS003 preclinical...
🔴 Nasus Pharma is trading 7.38% down in pre-market; no clear company-specific announcement identified
Nasus Pharma is trading 7.38% down at $3.20 after no clear company-specific announcement was identified for August 10, 2026. - Latest notable update: Brendan...
🔴 Nasus Pharma is trading 6.63% down today
Nasus Pharma is trading 6.63% down at $3.10 after falling from the August 5 close of $3.32, with no clear catalyst identified. - Searches found no new...
🟢 Nasus Pharma is trading 5.4% up today amid volatile small-cap trading
Nasus Pharma is trading 5.4% up now at $3.50 after rebounding from the August 5 close of $3.32. - Available coverage does not identify a new company-specific...
🔴 Nasus Pharma is trading 9.1% down today in a pullback after a two-day rally
Nasus Pharma is trading 9.1% down at $3.18 today in an apparent pullback following a sharp two-day rally and in the absence of any fresh, company-specific news...
🟢 Nasus Pharma is trading 6.1% up today, extending its rally amid strong risk-on sentiment
Nasus Pharma is trading at $3.50 (up 6.1%) in after-hours sessions, extending a multi-day rally driven by broader market strength and thin liquidity. • The...